SABCS 2022 Conference Coverage
A

SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen in Non-Invasive Breast Cancer

By SABCS 2022 Conference Coverage FEATURING Andrea De Censi
By SABCS 2022 Conference Coverage FEATURING Andrea De Censi
1,497 views
December 15, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Related Videos

10:53

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

Kirollos Hanna

2.2K views
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.4K views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
17:39

2023 Menopause Update

Yale School of Medicine

M. Minkin

9.1K views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

757 views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
05:43

Neoadjuvant Chemo for HR+ BC: Year in Review

Total Health

C. Ma

974 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
28:36

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials Inclu…

Insights from 2023 ASCO® Annual Meeting

H. Rugo, K. Jhaveri

4.8K views
09:19

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for Prem…

Insights from 2023 SABCS

K. Kalinsky

1.8K views
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views
27:01

CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC

Scripps Health

S. Sammons

1.7K views
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views
16:19

Optimizing Adjuvant Treatment in High-Risk HR+/HER2- eBC: Patient Se…

Wassim Mchayleh

883 views
22:34

What's New in Breast Cancer?

Dana-Farber Cancer Institute

S. Tolaney

1.6K views
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

932 views
09:12

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, …

2024 ESMO Annual Meeting Insights Hub

V. Kaklamani

503 views
38:49

ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

518 views
21:34

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

676 views
21:31

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

1.1K views
AUTOPLAY